(Q38091330)

28 August 2017

Conscious sedation for awake fibreoptic intubation: a review of the literature (English)

1 reference

28 August 2017

Kevin D Johnston

1

1 reference

PubMed ID

23512191

28 August 2017

Mridula R Rai

series ordinal

2

1 reference

28 August 2017

20 March 2013

1 reference

Canadian Journal of Anaesthesia

28 August 2017

1 reference

28 August 2017

60

1 reference

28 August 2017

6

1 reference

28 August 2017

584-599

1 reference

https://scigraph.springernature.com/pub.10.1007/s12630-013-9915-9

28 August 2017

0 references

cites work

Awake fibreoptic intubation in the patient at high risk of aspiration

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

A technique of awake fibreoptic intubation. Experience in patients with cervical spine disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Awake fibrecapnic intubation in head and neck cancer patients with difficult airways: new findings and refinements to the technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Fiberoptic intubation during remifentanil propofol sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

The use of propofol and remifentanil for the anaesthetic management of a super-obese patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Remifentanil-TCI and propofol-TCI for conscious sedation during fibreoptic intubation in the acromegalic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Effects of alfentanil on the responses to awake fiberoptic nasotracheal intubation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Frequent hypoxemia and apnea after sedation with midazolam and fentanyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Laryngeal incompetence during neuroleptanalgesia in combination with diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Measured context-sensitive half-times of remifentanil and alfentanil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Remifentanil for conscious sedation and analgesia during awake fiberoptic tracheal intubation: a case report with pharmacokinetic simulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Use of remifentanil for awake fiberoptic intubation in a morbidly obese patient with severe inflammation of the neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Evaluation of remifentanil as single drug for awake fiberoptic intubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Interactions between midazolam and remifentanil during monitored anesthesia care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Remifentanil as single agent to facilitate awake fibreoptic intubation in the absence of premedication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Remifentanil sedation for awake fibreoptic intubation with limited application of local anaesthetic in patients for elective head and neck surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

The effects of increasing plasma concentrations of dexmedetomidine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Difficult airway management in a patient with severe aortic stenosis, coronary artery disease, and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Awake intubation under sedation using target-controlled infusion of dexmedetomidine: five case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Dexmedetomidine sedation for awake fiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: a clinical series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Dexmedetomidine for awake fibreoptic intubation and awake self-positioning in a patient with a critically located cervical lesion for surgical removal of infra-tentorial tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Dexmedetomidine for awake fiberoptic intubation in a parturient with spinal muscular atrophy type III for cesarean delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Dexmedetomidine for an awake fiber-optic intubation of a parturient with Klippel-Feil syndrome, Type I Arnold Chiari malformation and status post released tethered spinal cord presenting for repeat cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Fiberoptic intubation with dexmedetomidine in two children with spinal cord impingements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Dexmedetomidine for fiberoptic intubation of a patient with severe mental retardation and atlantoaxial instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Dexmedetomidine as sole agent for awake fiberoptic intubation in a patient with local anesthetic allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Dexmedetomidine is a useful adjunct for awake intubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Progress in management of the obstructed airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Complete airway obstruction during awake fibreoptic intubation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Complete upper airway obstruction during awake fibreoptic intubation in patients with unstable cervical spine fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Total airway obstruction during local anesthesia in a non-sedated patient with a compromised airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Awake endotracheal intubation: a review of 267 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Training course in local anaesthesia of the airway and fibreoptic intubation using course delegates as subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Complications of awake fibreoptic intubation without sedation in 200 healthy anaesthetists attending a training course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

Target-controlled infusion of remifentanil to provide analgesia for awake nasotracheal fiberoptic intubations in cervical trauma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12630-013-9915-9

10.1007/S12630-013-9915-9

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

23512191

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23512191